Immuneering (IMRX) Amortization - Intangibles (2022 - 2026)
Immuneering's (IMRX) quarterly Amortization - Intangibles came in at $7317.0 in Q1 2026, little changed year-on-year from $7317.0 in Q1 2025, and little changed quarter-over-quarter from $7317.0 in Q4 2025.
Immuneering (IMRX) Amortization - Intangibles (2022 - 2026) Analysis & Trends
Immuneering's Amortization - Intangibles history runs 5 years deep, the most recent figure standing at $7317.0 for Q1 2026.
- On a quarterly basis, Amortization - Intangibles changed 0.0% year-over-year to $7317.0 in Q1 2026; TTM through Mar 2026 was $29268.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $29267.0, changed 0.0% from the prior year.
- Amortization - Intangibles held at $7317.0 in Q1 2026 per IMRX's latest filing, from $7317.0 in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $8103.0 in Q1 2022 and bottomed at $7316.0 in Q4 2022.
- The 5-year median for Amortization - Intangibles is $7317.0 (2022), against an average of $7363.2.
- Biggest YoY gain for Amortization - Intangibles was 0.01% in 2023; the steepest drop was 9.7% in 2023.
- Year by year, Amortization - Intangibles stood at $7316.0 in 2022, then gained by 0.01% to $7317.0 in 2023, then changed by 0.0% to $7317.0 in 2024, then changed by 0.0% to $7317.0 in 2025, then changed by 0.0% to $7317.0 in 2026.
- Per Business Quant, the three latest IMRX Amortization - Intangibles figures stand at $7317.0 (Q1 2026), $7317.0 (Q4 2025), and $7317.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Immuneering | 279.33 Mn | 279.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,317.00 |
| Dec 31, 2025 | 7,317.00 |
| Sep 30, 2025 | 7,317.00 |
| Jun 30, 2025 | 7,317.00 |
| Mar 31, 2025 | 7,317.00 |
| Dec 31, 2024 | 7,317.00 |
| Sep 30, 2024 | 7,317.00 |
| Jun 30, 2024 | 7,317.00 |
| Mar 31, 2024 | 7,317.00 |
| Dec 31, 2023 | 7,317.00 |
| Sep 30, 2023 | 7,317.00 |
| Jun 30, 2023 | 7,317.00 |
| Mar 31, 2023 | 7,317.00 |
| Dec 31, 2022 | 7,316.00 |
| Sep 30, 2022 | 7,317.00 |
| Jun 30, 2022 | 7,317.00 |
| Mar 31, 2022 | 8,103.00 |